Paper翻譯 (醫學的) 勿用機器~~

Therapies directed at the liver can thus have an impact on survival in the setting of metastatic CRC. Numerous cohort studies have shown a survival benefit for resection of hepatic metastases from CRC. The Registry of Hepatic Metastases collected data from 24 institutions over a 37-year period and determined... show more Therapies directed at the liver can thus have an
impact on survival in the setting of metastatic CRC.
Numerous cohort studies have shown a survival benefit
for resection of hepatic metastases from CRC. The Registry of Hepatic Metastases collected data from 24
institutions over a 37-year period and determined a
5-year survival rate of 33% after hepatic resection for
CRC metastases. Others have corroborated this with
5-year actuarial survival rates ranging from 28% to
58%. These studies have identified several adverse
prognostic factors in these patients. These include an
initially node-positive CRC,a disease-free interval of less
than 12 months, more than one liver metastasis, any
metastasis greater than 5 cm in size, a carcinoembryonic
antigen (CEA) level greater than 200, and a positive
resection margin.
1 answer 1